Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Feb;223(2):127–133. doi: 10.1097/00000658-199602000-00003

5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research.

X Pouliquen 1, H Levard 1, J M Hay 1, K McGee 1, A Fingerhut 1, O Langlois-Zantin 1
PMCID: PMC1235087  PMID: 8597505

Abstract

BACKGROUND: The curative rate of surgical resection of squamous cell carcinoma of the esophagus is low. Reports on the efficacy of preoperative and postoperative chemotherapy are conflicting or have included limited disease or radical surgery alone. OBJECTIVE: The authors' objective was to study the results of chemotherapy on the duration and quality of survival in patients who have undergone palliative surgical resection for esophageal squamous cell carcinoma. PATIENTS AND METHODS: Of 124 patients with histologically proven esophageal squamous cell carcinoma situated more than 5 cm from the upper end of the esophagus, 4 patients were withdrawn for failure to comply with the protocol. The remaining 120 patients, 116 males and 4 females (mean age, 57 +/- 9 years), were randomly assigned to either a control group who were to receive no chemotherapy (68 patients) or to a group who were to be treated with chemotherapy (52 patients). Patients were subdivided into two strata as follows: (1) stratum I, complete resection of the tumor with lymph node involvement (62 patients) and (2) stratum ii, incomplete resection leaving macroscopic tumor tissue in situ or with metastases. Noninclusion criteria were histologically proven tracheobronchial involvement, esotracheal fistula, major alteration of general health status (Karnofsky score <50), cerebral or extensive (>30% of parenchyma) hepatic metastasis, peritoneal carcinomatosis, associated or previously treated upper airway cancer, or, conversely, complete resection of tumor without lymph node involvement. Chemotherapy was given in 5-day courses, every 28 days, with a maximum of 8 courses. Cisplatin was administered either as a single dose of 100 mg/m2 at the beginning of the course or as 20 mg/m2/day for 5 days given over 3 hours. 5- Fluorouracil (5-FU) (100 mg/m2/day) was infused over 24 hours for 5 days. The duration of treatment ranged from 6 to 8 months. The main aim was to establish median survival and actuarial survival curves. The subsidiary aim was to evaluate quality of survival as judged by complications due to treatment and the duration of autonomous oral feeding, that is, without palliative endoscopic treatment. No difference in survival was noted between the two groups, overall (median, 14 months), or between the strata. Conversely, significantly more patients in the treated group had hematologic, neurologic, and renal complications compared with the control group. Four patients died of complications of chemotherapy. The duration of autonomous oral alimentation was exactly the same in both groups (median, 12 + months). CONCLUSION: The results of this study suggest that 5-FU and cisplatin are not useful for patients with squamous cell carcinoma of the esophagus who have not undergone curative resection.

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama H., Tsurumaru M., Kawamura T., Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg. 1981 Oct;194(4):438–446. doi: 10.1097/00000658-198110000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alberts A. S., Burger W., Greeff F., Schoeman L., Friediger D., Nel J., Steyn E., Schmid E. U., Falkson G. Severe complications of 5-fluorouracil and cisplatin with concomitant radiotherapy in inoperable non-metastatic squamous cell oesophageal cancer after intubation--early termination of a prospective randomised trial. Eur J Cancer. 1992;28A(4-5):1005–1006. doi: 10.1016/0959-8049(92)90172-x. [DOI] [PubMed] [Google Scholar]
  3. Carey R. W., Hilgenberg A. D., Wilkins E. W., Jr, Choi N. C., Mathisen D. J., Grillo H. C., Wain J. C., Logan D. L., Bromberg C. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest. 1993;11(2):99–105. doi: 10.3109/07357909309024826. [DOI] [PubMed] [Google Scholar]
  4. De Besi P., Sileni V. C., Salvagno L., Tremolada C., Cartei G., Fosser V., Paccagnella A., Peracchia A., Fiorentino M. Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer. Cancer Treat Rep. 1986 Jul;70(7):909–910. [PubMed] [Google Scholar]
  5. Earlam R., Cunha-Melo J. R. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980 Jun;67(6):381–390. doi: 10.1002/bjs.1800670602. [DOI] [PubMed] [Google Scholar]
  6. Elias D., Spielmann M., Kac J., Girinsky T., Guillot T., Pendola L., Bertin F., Escudier B., Rougier P., Lasser P. Cancers épidermoïdes de l'oesophage: l'association chimiothérapie puis chirurgie est-elle bénéfique? Bull Cancer. 1989;76(7):717–727. [PubMed] [Google Scholar]
  7. Ford C. D., VanMoorleghem G., Menlove R. L. Blood transfusions and postoperative wound infection. Surgery. 1993 Jun;113(6):603–607. [PubMed] [Google Scholar]
  8. Gignoux M., Roussel A., Paillot B., Gillet M., Schlag P., Favre J. P., Dalesio O., Buyse M., Duez N. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg. 1987 Aug;11(4):426–432. doi: 10.1007/BF01655805. [DOI] [PubMed] [Google Scholar]
  9. Gisselbrecht C., Calvo F., Mignot L., Pujade E., Bouvry M., Danne O., Belpomme D., Marty M. Fluorouracil (F), Adriamycin (A), and cisplatin (P) (FAP): combination chemotherapy of advanced esophageal carcinoma. Cancer. 1983 Sep 15;52(6):974–977. doi: 10.1002/1097-0142(19830915)52:6<974::aid-cncr2820520607>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  10. Goodner J. T. Surgical and radiation treatment of cancer of the thoracic esophagus. Am J Roentgenol Radium Ther Nucl Med. 1969 Mar;105(3):523–528. doi: 10.2214/ajr.105.3.523. [DOI] [PubMed] [Google Scholar]
  11. Herskovic A., Martz K., al-Sarraf M., Leichman L., Brindle J., Vaitkevicius V., Cooper J., Byhardt R., Davis L., Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992 Jun 11;326(24):1593–1598. doi: 10.1056/NEJM199206113262403. [DOI] [PubMed] [Google Scholar]
  12. Iizuka T., Ide H., Kakegawa T., Sasaki K., Takagi I., Ando N., Mori S., Arimori M., Tsugane S. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest. 1988 May;93(5):1054–1058. doi: 10.1378/chest.93.5.1054. [DOI] [PubMed] [Google Scholar]
  13. Iizuka T., Kakegawa T., Ide H., Ando N., Watanabe H., Tanaka O., Takagi I., Isono K., Ishida K., Arimori M. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992 Jun;22(3):172–176. [PubMed] [Google Scholar]
  14. Kasai M., Mori S., Watanabe T. Follow-up results after resection of thoracic esophageal carcinoma. World J Surg. 1978 Jul;2(4):543–551. doi: 10.1007/BF01563699. [DOI] [PubMed] [Google Scholar]
  15. Kelsen D., Hilaris B., Coonley C., Chapman R., Lesser M., Dukeman M., Heelan R., Bains M. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med. 1983 Oct;75(4):645–652. doi: 10.1016/0002-9343(83)90451-5. [DOI] [PubMed] [Google Scholar]
  16. Launois B., Delarue D., Campion J. P., Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet. 1981 Nov;153(5):690–692. [PubMed] [Google Scholar]
  17. Muir C. S. Epidémiologie du cancer de l'oesophage en France et dans le monde. Gastroenterol Clin Biol. 1981 Mar;5(3):239–242. [PubMed] [Google Scholar]
  18. Murray G. D. Statistical aspects of research methodology. Br J Surg. 1991 Jul;78(7):777–781. doi: 10.1002/bjs.1800780704. [DOI] [PubMed] [Google Scholar]
  19. Müller J. M., Erasmi H., Stelzner M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990 Aug;77(8):845–857. doi: 10.1002/bjs.1800770804. [DOI] [PubMed] [Google Scholar]
  20. Peracchia A., Bardini R., Castoro C., Sorrentino P., Segalin A., Ruol A., Asolati M., De Vido L. La lymphadénectomie dans le traitement du cancer de l'oesophage intrathoracique. A propos de l'étude de 240 cas. Ann Chir. 1990;44(1):9–17. [PubMed] [Google Scholar]
  21. Roth J. A., Pass H. I., Flanagan M. M., Graeber G. M., Rosenberg J. C., Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1988 Aug;96(2):242–248. [PubMed] [Google Scholar]
  22. Saikia T. K., Advani S. H., Ramakrishnan G., Swaroop S., Sharma S., Desai P. B. Intermediate-dose methotrexate and cisplatin in the treatment of advanced epidermoid esophageal carcinoma. Response rate and disease-free survival. Cancer. 1989 Jul 15;64(2):371–373. doi: 10.1002/1097-0142(19890715)64:2<371::aid-cncr2820640205>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  23. Schlag P. M. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg. 1992 Dec;127(12):1446–1450. doi: 10.1001/archsurg.1992.01420120080015. [DOI] [PubMed] [Google Scholar]
  24. Shields T. W., Rosen S. T., Hellerstein S. M., Tsang T., Ujiki G. T., Kies M. S. Multimodality approach to treatment of carcinoma of the esophagus. Arch Surg. 1984 May;119(5):558–562. doi: 10.1001/archsurg.1984.01390170054011. [DOI] [PubMed] [Google Scholar]
  25. Skinner D. B. Surgical treatment for esophageal carcinoma. Semin Oncol. 1984 Jun;11(2):136–143. [PubMed] [Google Scholar]
  26. Ténière P., Hay J. M., Fingerhut A., Fagniez P. L. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet. 1991 Aug;173(2):123–130. [PubMed] [Google Scholar]
  27. Wu Y. K., Huang K. C. Chinese experience in the surgical treatment of carcinoma of the esophagus. Ann Surg. 1979 Sep;190(3):361–365. doi: 10.1097/00000658-197909000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES